Sculptor Capital LP - BIOTECH ACQUISITION COMPANY ownership

BIOTECH ACQUISITION COMPANY's ticker is BIOTW and the CUSIP is G1125A116. A total of 56 filers reported holding BIOTECH ACQUISITION COMPANY in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Sculptor Capital LP ownership history of BIOTECH ACQUISITION COMPANY
ValueSharesWeighting
Q4 2022$9,323
+16.5%
150,0000.0%0.00%
Q3 2022$8,000
-20.0%
150,0000.0%0.00%
Q2 2022$10,000
-71.4%
150,0000.0%0.00%
Q1 2022$35,000
-62.8%
150,0000.0%0.00%
-100.0%
Q4 2021$94,000
-3.1%
150,0000.0%0.00%0.0%
Q3 2021$97,000
-25.4%
150,0000.0%0.00%0.0%
Q2 2021$130,000
+51.2%
150,0000.0%0.00%0.0%
Q1 2021$86,000150,0000.00%
Other shareholders
BIOTECH ACQUISITION COMPANY shareholders Q3 2022
NameSharesValueWeighting ↓
RAMIUS ADVISORS LLC 501,826$432,0000.16%
Kingstown Capital 300,000$258,0000.15%
Telemetry Investments, L.L.C. 85,000$73,0000.10%
Corbin Capital Partners, L.P. 464,062$399,0000.08%
Atalaya Capital Management LP 278,437$239,0000.06%
Radcliffe Capital Management, L.P. 202,950$1,963,0000.06%
Kamunting Street Capital Management, L.P. 158,962$137,0000.06%
DG Capital Management, LLC 224,999$193,0000.04%
MMCAP International Inc. SPC 300,000$258,0000.01%
PERISCOPE CAPITAL INC. 248,300$213,0000.01%
View complete list of BIOTECH ACQUISITION COMPANY shareholders